Exodus Point Capital Management, LP Amphastar Pharmaceuticals, Inc. Transaction History
Exodus Point Capital Management, LP
- $11.4 Billion
- Q2 2025
A detailed history of Exodus Point Capital Management, LP transactions in Amphastar Pharmaceuticals, Inc. stock. As of the latest transaction made, Exodus Point Capital Management, LP holds 32,444 shares of AMPH stock, worth $884,747. This represents 0.01% of its overall portfolio holdings.
Number of Shares
32,444
Previous 343,292
90.55%
Holding current value
$884,747
Previous $9.95 Million
92.51%
% of portfolio
0.01%
Previous 0.1%
Shares
10 transactions
Others Institutions Holding AMPH
# of Institutions
257Shares Held
33.3MCall Options Held
18.3KPut Options Held
12.6K-
Black Rock Inc. New York, NY5.94MShares$162 Million0.01% of portfolio
-
Vanguard Group Inc Valley Forge, PA2.69MShares$73.3 Million0.0% of portfolio
-
Td Asset Management Inc2.03MShares$55.5 Million0.04% of portfolio
-
Dimensional Fund Advisors LP Austin, TX1.63MShares$44.4 Million0.01% of portfolio
-
State Street Corp Boston, MA1.58MShares$43 Million0.0% of portfolio
About Amphastar Pharmaceuticals, Inc.
- Ticker AMPH
- Exchange NASDAQ
- Sector Healthcare
- Industry Drug Manufacturers—Specialty & Generic
- Shares Outstandng 49,015,200
- Market Cap $1.34B
- Description
- Amphastar Pharmaceuticals, Inc., a bio-pharmaceutical company, develops, manufactures, markets, and sells generic and proprietary injectable, inhalation, and intranasal products in the United States, China, and France. The company operates through two segments, Finished Pharmaceutical Products and API. It offers Primatene Mist, an over-the-count...